169 related articles for article (PubMed ID: 33088568)
1. Mucinous adenocarcinoma of the prostatic urethra following a remote history of primary brachytherapy for prostate cancer.
Peak TC; Goodman MM; Fenu EM; Hemal AK
SAGE Open Med Case Rep; 2020; 8():2050313X20959867. PubMed ID: 33088568
[TBL] [Abstract][Full Text] [Related]
2. Mucinous adenocarcinoma of the prostatic urethra after brachytherapy for prostatic adenocarcinoma: a case series.
Zhao T; Chuang HW; Cornejo KM; Crotty RK; Dahl DM; Wszolek MF; Zlatev DV; Zietman AL; Wu CL
Hum Pathol; 2022 Oct; 128():101-109. PubMed ID: 35926810
[TBL] [Abstract][Full Text] [Related]
3. Urethral Mucinous Adenocarcinoma of the Prostate: An Uncommon and Diagnostically Complex Disease.
Wang A; Lam MK; Isharwal S
Urology; 2020 Dec; 146():e1-e2. PubMed ID: 33045285
[TBL] [Abstract][Full Text] [Related]
4. Clear cell adenocarcinoma of the prostatic urethra: A case report.
Sugimura R; Kawahara T; Noguchi G; Takamoto D; Izumi K; Miyoshi Y; Kishida T; Yao M; Tanabe M; Uemura H
IJU Case Rep; 2019 Jan; 2(1):19-22. PubMed ID: 32743364
[TBL] [Abstract][Full Text] [Related]
5. Case Report: Prostate Adenocarcinoma With Mucinous Features of Normal-Level Serum PSA, Atypical Imaging, Biopsy-Negative, and Peculiar Urethrocystoscopic Manifestation.
Zhang Y; Shen H; Liao K; Wu W; Li J; Yu H; Wu H; Wang Z
Front Oncol; 2020; 10():504381. PubMed ID: 33425711
[TBL] [Abstract][Full Text] [Related]
6. Difficulty in distinguishing radiation-induced prostate sarcoma from radiation mucositis in a patient with persistent urinary retention and hematuria after prostate cancer radiotherapy.
Hiraoka S; Imagumbai T; Kosaka Y; Ogura K; Hattori T; Ogata T; Yamashita D; Kawakita M; Kokubo M
Int Cancer Conf J; 2020 Jul; 9(3):133-136. PubMed ID: 32582517
[TBL] [Abstract][Full Text] [Related]
7. [Two cases of mucinous adenocarcinoma of the prostate].
Ishibashi Y; Kishida T; Yamaguchi T; Sugawara T; Satomi Y
Hinyokika Kiyo; 1992 Apr; 38(4):463-7. PubMed ID: 1326881
[TBL] [Abstract][Full Text] [Related]
8. [Mucinous Adenocarcinoma of the Prostate Diagnosed after Transurethral Treatment of a Prostatic Abscess].
Yokokawa S; Ito H; Shinoki R; Tsuura Y; Kobayashi K
Hinyokika Kiyo; 2021 Sep; 67(9):427-431. PubMed ID: 34610709
[TBL] [Abstract][Full Text] [Related]
9. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.
Osunkoya AO; Epstein JI
Am J Surg Pathol; 2007 Sep; 31(9):1323-9. PubMed ID: 17721186
[TBL] [Abstract][Full Text] [Related]
10. Clear cell adenocarcinoma of the prostatic urethra with metachronous prostate adenocarcinoma.
Wang H; Ting F; Samra S; Mcleod D; Nalavenkata S; Kim L
Urol Case Rep; 2023 Mar; 47():102338. PubMed ID: 36816610
[TBL] [Abstract][Full Text] [Related]
11. Mucinous urothelial-type adenocarcinoma of the prostate.
Ortiz-Rey JA; Dos Santos JE; Rodríguez-Castilla M; Alvarez C; Fariña L
Scand J Urol Nephrol; 2004; 38(3):256-7. PubMed ID: 15204383
[TBL] [Abstract][Full Text] [Related]
12. Radiation-induced leiomyosarcoma of the prostate after brachytherapy for prostatic adenocarcinoma.
Horiguchi H; Takada K; Kamihara Y; Ibata S; Iyama S; Sato T; Hayashi T; Miyanishi K; Sato Y; Takimoto R; Kobune M; Kobayashi K; Hirayama Y; Masumori N; Hasegawa T; Kato J
Case Rep Oncol; 2014 May; 7(2):565-70. PubMed ID: 25232328
[TBL] [Abstract][Full Text] [Related]
13. Angiosarcoma of the Prostate Gland following Brachytherapy for Prostatic Adenocarcinoma.
Gupta A; Patnaik MM; Naina HV
Curr Urol; 2015 Jul; 8(2):109-12. PubMed ID: 26889128
[TBL] [Abstract][Full Text] [Related]
14. Mucinous Bladder Adenocarcinoma: Case Report and Literature Review.
Santos BM; de Souza JD; Lima RS; de Lima EM
Case Rep Urol; 2015; 2015():783109. PubMed ID: 26421206
[TBL] [Abstract][Full Text] [Related]
15. Secondary mucinous carcinoma of the prostate after low dose rate brachytherapy.
Murchison SC; Martens MB; Truong P; Alexander A
Can J Urol; 2018 Apr; 25(2):9284-9287. PubMed ID: 29680008
[TBL] [Abstract][Full Text] [Related]
16. The dosimetry of prostate brachytherapy-induced urethral strictures.
Merrick GS; Butler WM; Tollenaar BG; Galbreath RW; Lief JH
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):461-8. PubMed ID: 11872293
[TBL] [Abstract][Full Text] [Related]
17. Systemic treatment for coexisting mucinous urethral adenocarcinoma and prostate adenocarcinoma.
Nezu K; Okubo T; Shiraiwa M; Nozawa Y; Kyan A
IJU Case Rep; 2020 Nov; 3(6):261-264. PubMed ID: 33163919
[TBL] [Abstract][Full Text] [Related]
18. Radioactive seed migration after transperineal interstitial prostate brachytherapy and associated development of small-cell lung cancer.
Chen WC; Katcher J; Nunez C; Tirgan AM; Ellis RJ
Brachytherapy; 2012; 11(5):354-8. PubMed ID: 22244438
[TBL] [Abstract][Full Text] [Related]
19. Mucin-producing tumors and tumor-like lesions involving the prostate: a comprehensive review.
Bohman KD; Osunkoya AO
Adv Anat Pathol; 2012 Nov; 19(6):374-87. PubMed ID: 23060063
[TBL] [Abstract][Full Text] [Related]
20. Intestinal-type mucinous adenocarcinoma arising from the prostatic duct.
Sakamoto N; Ohtsubo S; Iguchi A; Takeshita M; Kurozumi T
Int J Urol; 2005 May; 12(5):509-12. PubMed ID: 15948756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
